Brain-Derived Neurotrophic Factor Signaling Modulates Cocaine Induction of Reward-Associated Ultrasonic Vocalization in Rats

  1. Stacey N. Williams and
  2. Ashiwel S. Undieh
  1. Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland (S.N.W.); and Laboratory of Integrative Neuropharmacology, Department of Pharmaceutical Sciences, Thomas Jefferson University School of Pharmacy, Philadelphia, Pennsylvania (A.S.U.)
  1. Address correspondence to:
    Dr. Ashiwel S. Undieh,
    Professor and Chair, Department of Pharmaceutical Sciences, Thomas Jefferson University School of Pharmacy, 130 S. 9th St., Suite 1540, Philadelphia, PA 19107.
    E-mail: ashiwel.undieh{at}jefferson.edu

Abstract

Cocaine exhibits high liability for inducing addictive behaviors, but the mechanisms of neuroplasticity underlying the behavioral effects remain unclear. As a crucial mediator of neuroplasticity in diverse functional models, brain-derived neurotrophic factor (BDNF) could contribute to the mechanisms of addiction-related neuroplasticity. Here, we addressed the hypothesis that cocaine increases synaptic dopamine, which induces BDNF protein expression to initiate addiction-related behavior in the rat. An enzyme-linked immunosorbent assay was used to measure BDNF protein expression in rat striatal tissues. For behavioral readout, we used a noninvasive measurement system to measure the emission of 50-kHz ultrasonic vocalization (USV), a response that correlates with electrical brain stimulation and conditioned place preference behavior in rodents. A single injection of cocaine significantly increased BDNF protein expression, but this effect was not further augmented by repeated cocaine administration. A single administration of cocaine elicited significant and dose-related USV responses, and the magnitude of the behavior increased with repeated drug administration. R-(+)-7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SCH23390), but not raclopride, significantly attenuated cocaine-induced BDNF protein expression, whereas either the D1-like or D2-like receptor antagonist blocked cocaine-induced USV behavior. Furthermore, significant USV behavior was elicited by the nonselective dopamine agonist, apomorphine, but not by agonists that are selective for D1-like or D2-like receptors. Intracerebroventricular injection of the neurotrophin TrkB receptor inhibitor, K252a, blocked cocaine-induced USV behavior but not locomotor activity. These results suggest that neurotrophin signaling downstream of dopamine receptor function probably constitutes a crucial link in cocaine induction of USV behavior and may contribute to the mechanisms underlying the development of addiction-related behaviors.

Footnotes

  • This work was supported by the National Institutes of Health National Institute on Drug Abuse [Grant R01-DA017614].

  • Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.

    doi:10.1124/jpet.109.158535

  • ABBREVIATIONS:

    BDNF
    brain-derived neurotrophic factor
    SKF38393
    (±)-1-phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol
    SCH23390
    R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine
    ELISA
    enzyme-linked immunosorbent assay
    USV
    50-kHz ultrasonic vocalization
    ANOVA
    analysis of variance
    NAc
    nucleus accumbens.

    • Received July 9, 2009.
    • Accepted October 20, 2009.
« Previous | Next Article »Table of Contents

This Article

  1. JPET February 2010 vol. 332 no. 2 463-468
  1. » Abstract
  2. Full Text
  3. Full Text (PDF)
  4. All Versions of this Article:
    1. jpet.109.158535v1
    2. 332/2/463 most recent

Classifications

Responses

  1. Submit a response
  2. No responses published